Long-term plasmapheresis and protein A column treatment of recurrent FSGS

[1]  M. Steffes,et al.  Glomerular cell number in normal subjects and in type 1 diabetic patients. , 2001, Kidney international.

[2]  V. Savin,et al.  Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. , 2000, Kidney international.

[3]  M. Moritz,et al.  Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts , 2000, Pediatric Nephrology.

[4]  J. Subra,et al.  Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies. , 1999, Journal of the American Society of Nephrology : JASN.

[5]  P. Singhal,et al.  Circulating factor in patients with recurrent focal segmental glomerulosclerosis postrenal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[6]  V. Savin,et al.  "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. , 1999, Journal of the American Society of Nephrology : JASN.

[7]  R. Ouseph,et al.  Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry. , 1999, Transplantation proceedings.

[8]  V. Savin,et al.  Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP. , 1996, Transplantation.

[9]  S. Swan,et al.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. , 1996, The New England journal of medicine.

[10]  V. Savin,et al.  Cyclosporine prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerular sclerosis. , 1996, Transplantation.

[11]  G. Remuzzi,et al.  The effects of nonsteroidal anti-inflammatory drugs on glomerular filtration of proteins and their therapeutic utility. , 1995, Seminars in Nephrology.

[12]  A. Sedman,et al.  Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide. , 1994, Clinical transplantation.

[13]  S. Kagami,et al.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. , 1994, The Journal of clinical investigation.

[14]  V. Savin,et al.  Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  K. Yoshioka,et al.  Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[16]  R. Ettenger,et al.  Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis. , 1993, Transplantation proceedings.

[17]  A. Tejani,et al.  Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. , 1992, Journal of the American Society of Nephrology : JASN.

[18]  S. Tomlanovich,et al.  Recurrent focal glomerulosclerosis: natural history and response to therapy. , 1992, The American journal of medicine.

[19]  E. Ingulli,et al.  Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience. , 1991, Transplantation.

[20]  G. Feutren,et al.  Serum creatinine in cyclosporin-induced remission of steroid-resistant nephrotic syndrome , 1990, The Lancet.

[21]  C. Chantler,et al.  Focal segmental glomerulosclerosis in fifty-nine renal allografts from a single centre; analysis of risk factors for recurrence. , 1989, Transplantation proceedings.

[22]  S. Mauer,et al.  Recurrence of focal segmental sclerosis in children following renal transplantation. , 1986, Kidney international. Supplement.

[23]  S. Zimmerman Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis. , 1985, Nephron.

[24]  J. Cameron,et al.  Recurrence of focal segmental glomerulosclerosis in renal allografts. , 1981, Transplantation.

[25]  J. Briner,et al.  Recurrence of focal segmental glomerulosclerosis in the transplanted kidney. , 1980, Nephron.